Permanent employee, Full-time · Planegg (Germany)
As a member of our CMC team, you will support and shape the development of innovative biopharmaceuticals, taking responsibility for the oversight of external analytical development activities at CDMOs and CROs for antibodies, small molecules, and antibody–drug conjugates (ADCs). You will work in a highly interdisciplinary environment with opportunities to continuously expand your technical expertise and adopt new analytical approaches.
Proficient in spoken and written English.
At Tubulis, your ideas matter, your growth matters—and together we make a difference.
Tubulis is a clinical stage biotech company that generates uniquely matched antibody‑drug conjugates (ADCs) with superior biophysical properties that have demonstrated durable on‑tumor delivery and long‑lasting anti‑tumor activity in pre‑clinical models. We recently closed on a Series C fundraising round totaling €344 M (US $401 M).
The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and ADCs. With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world‑wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.
#J-18808-LjbffrVeröffentlichungsdatum:
24 Mär 2026Standort:
PlaneggTyp:
VollzeitArbeitsmodell:
Vor OrtKategorie:
Erfahrung:
2+ yearsArbeitsverhältnis:
Angestellt
Möchtest über ähnliche Jobs informiert werden? Dann beauftrage jetzt den Fuchsjobs KI Suchagenten!